S

SymBio Pharmaceuticals Ltd
TSE:4582

Watchlist Manager
SymBio Pharmaceuticals Ltd
TSE:4582
Watchlist
Price: 90 JPY -1.1%
Market Cap: 5B JPY

Intrinsic Value

The intrinsic value of one SymBio Pharmaceuticals Ltd stock under the Base Case scenario is 69.85 JPY. Compared to the current market price of 90 JPY, SymBio Pharmaceuticals Ltd is Overvalued by 22%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
69.85 JPY
Overvaluation 22%
Intrinsic Value
Price
S
Worst Case
Base Case
Best Case

Valuation History
SymBio Pharmaceuticals Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about SymBio Pharmaceuticals Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is SymBio Pharmaceuticals Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for SymBio Pharmaceuticals Ltd.

Explain Valuation
Compare SymBio Pharmaceuticals Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about SymBio Pharmaceuticals Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
SymBio Pharmaceuticals Ltd

Current Assets 4.5B
Cash & Short-Term Investments 3.5B
Receivables 195.6m
Other Current Assets 876.7m
Non-Current Assets 44m
Long-Term Investments 15k
Other Non-Current Assets 44m
Current Liabilities 582.8m
Other Current Liabilities 582.8m
Non-Current Liabilities 2.3B
Long-Term Debt 2.3B
Other Non-Current Liabilities 4.8m
Efficiency

Free Cash Flow Analysis
SymBio Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
SymBio Pharmaceuticals Ltd

Revenue
1.5B JPY
Cost of Revenue
-401.1m JPY
Gross Profit
1.1B JPY
Operating Expenses
-5.5B JPY
Operating Income
-4.4B JPY
Other Expenses
-128.8m JPY
Net Income
-4.6B JPY
Fundamental Scores

Profitability Score
Profitability Due Diligence

SymBio Pharmaceuticals Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Declining Gross Margin
Declining Net Margin
15/100
Profitability
Score

SymBio Pharmaceuticals Ltd's profitability score is 15/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

SymBio Pharmaceuticals Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
Average D/E
38/100
Solvency
Score

SymBio Pharmaceuticals Ltd's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
SymBio Pharmaceuticals Ltd

There are no price targets for SymBio Pharmaceuticals Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

SymBio Pharmaceuticals Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for SymBio Pharmaceuticals Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one SymBio Pharmaceuticals Ltd stock?

The intrinsic value of one SymBio Pharmaceuticals Ltd stock under the Base Case scenario is 69.85 JPY.

Is SymBio Pharmaceuticals Ltd stock undervalued or overvalued?

Compared to the current market price of 90 JPY, SymBio Pharmaceuticals Ltd is Overvalued by 22%.

Back to Top